| Literature DB >> 28361513 |
Hyun Hwan Sung1, Kwang Jin Ko1, Yoon Seok Suh2, Gyu Ha Ryu3, Kyu-Sung Lee1,4.
Abstract
PURPOSE: This study aimed to investigate the surgical outcomes and safety of robotic sacrocolpopexy (RSC) in patients with uterine/vaginal vault prolapse.Entities:
Keywords: Pelvic Organ Prolapse; Robotic Sacrocolpopexy; Robotic Surgical Procedures; Uterine Prolapse
Year: 2017 PMID: 28361513 PMCID: PMC5380819 DOI: 10.5213/inj.1732642.321
Source DB: PubMed Journal: Int Neurourol J ISSN: 2093-4777 Impact factor: 2.835
Baseline characteristics (n=16)
| Variable | Value |
|---|---|
| Age (yr) | 65 (56–68) |
| Body mass index (kg/m2) | 25.4 (24.0–28.3) |
| Follow-up duration (mo) | 25.3 (5.4–34.0) |
| ASA PS classification, grade | II (I–III) |
| Previous abdominal surgery | 6 (37.5) |
| Hysterectomy | 5 (31.3) |
| Salpingo-oophorectomy | 1 (6.3) |
| Previous POP repair | 2 (12.5) |
| Stress incontinence | 11 (68.8) |
| Grade I | 7 (43.8) |
| Grade II | 4 (25.0) |
| Previous anti-incontinence surgery | 2 (12.5) |
| Uterine/vaginal vault prolapse | |
| Grade II | 3 (18.8) |
| Grade III | 10 (62.5) |
| Grade IV | 3 (18.8) |
Values are presented as median (interquartile range) or number (%).
ASA PS, American Society of Anesthesiologists physical status; POP, pelvic organ prolapse.
Surgical outcomes of robotic sacrocolpopexy (n=16)
| Variable | Value |
|---|---|
| Operation time (min) | 251 (236–288) |
| Estimated blood loss (mL) | 75 (50–150) |
| Combined operation | 9 (56.3) |
| Midurethral sling | 8 (50.0) |
| Cystocele repair | 1 (6.3) |
| Conversion to open surgery | 0 (0) |
| Hospital stay (day) | 4 (3–5) |
| Uterine/vaginal vault prolapse | |
| Grade 0 | 8 |
| Grade I | 6 |
| Success at last follow-up | 14 (100)[ |
| Recurrence at last follow-up | 0 (0) |
Values are presented as median (interquartile range) or number (%).
Only 14 women were measured by the questionnaire before the operation and at the final follow-up.
Measurement of pelvic organ prolapse by using pelvic organ prolapse quantification examination (n=14)
| Point | Preoperative | Postoperative | P-value[ |
|---|---|---|---|
| Aa point | 3 (1–3) | -2 (-2 to 0) | 0.002 |
| Ba point | 3 (3–5) | -2 (-2 to -1) | 0.001 |
| C point | 4 (2–5) | -6 (-8 to -5) | 0.001 |
| Ap point | -2 (-2 to 3) | -2 (-3 to -2) | 0.016 |
| Bp point | 2 (-2 to 3) | -2 (-3 to -2) | 0.002 |
| gh | 5 (4–6) | - | - |
| pb | 3 (2–4) | - | - |
| tvl | 8 (7–9) | - | - |
Aa, point A anterior; Ap, point A posterior; Ba, point B anterior; Bb, point B posterior; C, cervix or vaginal cuff; gh, genital hiatus; pb, perineal body; tvl, total vaginal length.
Wilcoxon signed-rank test.
Fig. 1.Measurement of patient-reported outcomes for robotic sacrocolpopexy by using pelvic floor distress inventory-short form 20.
Detailed description of perioperative complications
| Complication | No. (%) | Detail |
|---|---|---|
| Intraoperative complication | 1 (6.3) | Sacral venous plexus injury causing massive bleeding |
| Postoperative complication[ | ||
| Grade I | 3 (18.8) | Headache (n=1), nausea (n=1), transient nerve palsy (n=1) |
| Grade II | 1 (6.3) | Postoperative transfusion (n=1) |
Using Clavien-Dindo complication classification.